Could insulin eye drops save your sight?
NCT ID NCT05206877
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests whether insulin eye drops are safe for people with glaucoma and other optic nerve conditions. Researchers at Stanford will give different doses of insulin drops to 52 participants for 1-2 months. The main goal is to check for side effects, but they will also measure any changes in retinal thickness and vision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- insulin eye drops
- What this could lead to
- If safe, this could point toward a new way to protect vision in people with glaucoma or other optic nerve diseases.
- What could go wrong
- This is a very early Phase 1 safety trial with only 52 people. It is not designed to prove the drops improve vision, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Byers Eye Institute at Stanford University
RECRUITINGPalo Alto, California, 94303, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Could your personality predict glaucoma drug side effects?
- Could a single eye implant replace years of glaucoma drops?